{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:20:26Z","timestamp":1788877226672,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["T-B-031"],"award-info":[{"award-number":["T-B-031"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.numecd.2024.02.014","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T16:33:34Z","timestamp":1709570014000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development of a machine learning-based model for predicting individual responses to antihypertensive treatments"],"prefix":"10.1016","author":[{"given":"Jiayi","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6153-5568","authenticated-orcid":false,"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-4989","authenticated-orcid":false,"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10226","key":"10.1016\/j.numecd.2024.02.014_bib1","first-page":"795","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (London, England)","volume":"395","author":"Yusuf","year":"2020","journal-title":"Mar 7"},{"issue":"10017","key":"10.1016\/j.numecd.2024.02.014_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","article-title":"Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis","volume":"387","author":"Xie","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"7","key":"10.1016\/j.numecd.2024.02.014_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis","volume":"2","author":"Bundy","year":"2017","journal-title":"JAMA cardiology"},{"issue":"10304","key":"10.1016\/j.numecd.2024.02.014_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.numecd.2024.02.014_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028573","article-title":"Antihypertensive medication regimens used by US adults with hypertension and the potential for fixed-dose combination products: the national health and nutrition examination surveys 2015 to 2020","volume":"12","author":"Derington","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.numecd.2024.02.014_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023397","article-title":"Malignant hypertension: current perspectives and challenges","volume":"11","author":"Boulestreau","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.numecd.2024.02.014_bib7","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/HYPERTENSIONAHA.121.18884","article-title":"How to improve awareness, treatment, and control of hypertension in africa, and how to reduce its consequences: a call to action from the world hypertension league","volume":"79","author":"Parati","year":"2022","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.numecd.2024.02.014_bib8","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.2023.3704","article-title":"Is personalized antihypertensive drug selection feasible?","volume":"329","author":"Carey","year":"2023","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.numecd.2024.02.014_bib9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jama.2023.3322","article-title":"Heterogeneity in blood pressure response to 4 antihypertensive drugs: a randomized clinical trial","volume":"329","author":"Sundstr\u00f6m","year":"2023","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.numecd.2024.02.014_bib10","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1016\/S2589-7500(22)00170-4","article-title":"Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials","volume":"4","author":"Oikonomou","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.014_bib11","first-page":"Np485","article-title":"Time to achieve first blood pressure control after diagnosis among hypertensive patients at primary health care clinics: a preliminary study. Asia Pac J Public Health","volume":"27","author":"Cheong","year":"2015","journal-title":"Mar"},{"issue":"7","key":"10.1016\/j.numecd.2024.02.014_bib12","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCRESAHA.121.318106","article-title":"Artificial intelligence in hypertension: seeing through a glass darkly","volume":"128","author":"Padmanabhan","year":"2021","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.numecd.2024.02.014_bib13","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/HJH.0000000000001052","article-title":"Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials","volume":"34","author":"Thomopoulos","year":"2016","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.014_bib14","article-title":"Machine Learning-Based prediction of Post-Treatment ambulatory blood pressure in patients with hypertension","volume":"32","author":"Hae","year":"2023","journal-title":"Blood Pres"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.014_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003825.pub2","article-title":"Blood pressure lowering efficacy of loop diuretics for primary hypertension","author":"Musini","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.numecd.2024.02.014_bib16","article-title":"Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension","author":"Musini","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.014_bib17","article-title":"Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension","author":"Chen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"7404","key":"10.1016\/j.numecd.2024.02.014_bib18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.numecd.2024.02.014_bib19","article-title":"Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension","volume":"11","author":"Heran","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.numecd.2024.02.014_bib20","article-title":"Blood pressure lowering efficacy of alpha blockers for primary hypertension","author":"Heran","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.014_bib21","article-title":"Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension","volume":"2008","author":"Heran","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.014_bib22","article-title":"Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension","volume":"2008","author":"Heran","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.numecd.2024.02.014_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104243","article-title":"Machine learning integration of multimodal data identifies key features of blood pressure regulation","volume":"84","author":"Louca","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.014_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13063-022-06374-x","article-title":"Effectiveness of a clinical decision support system for hypertension management in primary care: study protocol for a pragmatic cluster-randomized controlled trial","volume":"23","author":"Song","year":"2022","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.014_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.numecd.2024.02.014_bib26","first-page":"590","article-title":"Antihypertensive medication regimens used in the systolic blood pressure intervention trial. Hypertension","volume":"80","author":"Derington","year":"2023","journal-title":"Mar"},{"issue":"12","key":"10.1016\/j.numecd.2024.02.014_bib27","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jash.2016.10.005","article-title":"Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction","volume":"10","author":"Levy","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"8","key":"10.1016\/j.numecd.2024.02.014_bib28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/HYPERTENSIONAHA.123.21132","article-title":"Single-pill combination product availability of the antihypertensive regimens used for intensive systolic blood pressure treatment in the systolic blood pressure intervention trial","volume":"80","author":"King","year":"2023","journal-title":"Hypertension"},{"issue":"19","key":"10.1016\/j.numecd.2024.02.014_bib29","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.02.014_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2023.120470","article-title":"Developing machine learning approaches to identify candidate persistent, mobile and toxic (PMT) and very persistent and very mobile (vPvM) substances based on molecular structure","volume":"244","author":"Han","year":"2023","journal-title":"Water Res"},{"issue":"30","key":"10.1016\/j.numecd.2024.02.014_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004071","article-title":"Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement","volume":"95","author":"Paz","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"8","key":"10.1016\/j.numecd.2024.02.014_bib32","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/HJH.0b013e32836157be","article-title":"Blood pressure response with fixed-dose combination therapy: comparing hydrochlorothiazide with amlodipine through individual-level meta-analysis","volume":"31","author":"Agarwal","year":"2013","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.numecd.2024.02.014_bib33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2018.07.008","article-title":"Prevention and control of hypertension: JACC health promotion series","volume":"72","author":"Carey","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.numecd.2024.02.014_bib34","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCRESAHA.120.318729","article-title":"Hypertension in low- and middle-income countries","volume":"128","author":"Schutte","year":"2021","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.numecd.2024.02.014_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/jch.13874","article-title":"Hypertension control in sub-Saharan Africa: clinical inertia is another elephant in the room","volume":"22","author":"van der Linden","year":"2020","journal-title":"J Clin Hypertens"},{"issue":"1","key":"10.1016\/j.numecd.2024.02.014_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11906-018-0802-1","article-title":"Therapeutic inertia and treatment intensification","volume":"20","author":"Josiah Willock","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"10.1016\/j.numecd.2024.02.014_bib37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jash.2009.03.001","article-title":"A narrative review of clinical inertia: focus on hypertension","volume":"3","author":"Faria","year":"2009","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"10.1016\/j.numecd.2024.02.014_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/dis.2008.1120007","article-title":"Identifying barriers to hypertension care: implications for quality improvement initiatives","volume":"11","author":"Holland","year":"2008","journal-title":"Dis Manag"},{"issue":"13","key":"10.1016\/j.numecd.2024.02.014_bib39","first-page":"21","article-title":"Pharmacogenomics of hypertension treatment","author":"Rysz","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2 Pt 2","key":"10.1016\/j.numecd.2024.02.014_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0002-8703(93)90210-Z","article-title":"Hypertension and the kidney: determinants of the response to antihypertensive therapy and their implications","volume":"125","author":"Hollenberg","year":"1993","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2024.02.014_bib41","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cvr\/cvac116","article-title":"A functional connectome signature of blood pressure in >30 000 participants from the UK biobank","volume":"119","author":"Jiang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2024.02.014_bib42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/IBPC.S152761","article-title":"White coat syndrome and its variations: differences and clinical impact","volume":"11","author":"Pioli","year":"2018","journal-title":"Integrated Blood Pres Control"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T13:47:35Z","timestamp":1714139255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"alternative-id":["S0939475324000863"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.02.014","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a machine learning-based model for predicting individual responses to antihypertensive treatments","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}